Hill-Rom Holdings's EBIT is $900M, below the Healthcare sector average of $23B.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2021
Trailing 12 months ending Sep 30, 2021
Hill-Rom Holdings (HRC) currently reports a EBIT of $900M as of September 2021. That compares with $410M in the prior-year period — up 118.8% year over year. That is below the Healthcare sector average of $23B. Use the charts on this page to explore Hill-Rom Holdings's EBIT history and peer comparisons.
Hill-Rom Holdings's EBIT increased from $410M to $900M — a 118.8% year-over-year increase (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Hill-Rom Holdings's EBIT of $900M is lower than the Healthcare sector average of $23B. That is roughly 96.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
Hill-Rom Holdings reported $900M in EBIT as of September 2021. That compares with $410M in the prior-year period — up 118.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current EBIT of $900M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $23B. From there, open related valuation or income-statement pages for Hill-Rom Holdings, and consider following HRC for alerts when major investors trade the stock.